Telehealth and Pharmacological Strategies of COVID-19 Prevention: Current and Future Developments

After the identification of SARS-CoV-2 virus in China, it has spread worldwide at a rapid pace. To control novel coronavirus disease (COVID-19), there is no particular treatments/immunizations are available yet. However, to avoid the risk of immediate spreading between infected individuals, and healthcare workers, most organizations adopting virtual media devices in order asses the symptomatic behaviour of patient and these services are well known for telehealth services. On other hand, repositioning of drugs can offer a controlling strategy, and several drugs including remdesivir, lopinavir/ritonavir, hydroxychloroquine (HCQ), and favipiravir were repurposed. The availability of an authenticated vaccine against COVID19 will be hard to produce in the coming days, therefore it is important to propose a pharmacological strategy to combat this disease. In this chapter, the authors present the investigation of controlling and preventing methods by telemedical services during a novel coronavirus outbreak. Besides, it can also report the current drug available information and future developments that need to present new strategies for developing pharmacy facilities.